Hence, elevated systemic EPO levels would be expected in this scenario; however, Cakmak et al. analyzed EPO levels in patients with idiopathic and secondary polycythemia and found no significant difference between the two groups, suggesting that systemic EPO levels may have limited utility in distinguishing these conditions [5]. This evidence concerns the gene EPO and polycythemia.